Retail sale of pharmaceutical products
PCG PHARMACIES AS
Revenue 2024
NOK 26.4m
Operating profit
NOK 977,000
Equity
NOK 953,000
Incorporated
2018
Employees
15
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 26.4m | |
| Total operating costs | 25.4m | |
| Operating profit (EBIT) | 977k | |
| Net financial items | −20k | |
| Profit for the year | 745k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 5.0m | |
| of which current assets | 4.8m | |
| Equity | 953k | |
| Total liabilities | 4.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.